Pancreatic neuroendocrine tumors;Tumores neuroendocrinos del páncreas

Revista Medica de Chile

Volumn 132, Issue 5, 2004, Pages 627-634

  Burgos S J, Luis ^a,b   Burgos De C, María Eugenia ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b NONE   (Chile)

Author keywords

Langerhans cells; Neuroendocrine tumors; Pancreatic neoplasms

Indexed keywords

PANTOPRAZOLE;

CANCER SURGERY; GASTRINOMA; GLUCAGONOMA; HUMAN; HYPERGASTRINEMIA; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL; PANCREAS TUMOR; REVIEW; SOMATOSTATINOMA; TREATMENT OUTCOME; TUMOR VOLUME; VIPOMA; VON HIPPEL LINDAU DISEASE; ZOLLINGER ELLISON SYNDROME;

GASTRINOMA; HUMANS; INSULINOMA; MALE; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; SOMATOSTATINOMA; VIPOMA;

EID: 12544252843     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. AZIMUDDIN K, CHAMBERLAIN R. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001; 281: 511-25.
2. KENT RB, VAN HEERDEN J, NEJLAND L. Non-functioning islet cell tumors. Ann Surg 1981; 193: 185-90.
3. YANG CS, SHYR YM, CHIU CT ET AL. Non-functioning islet cell tumors of the pancreas a multicentric clinical study in Taiwan. Hepatogastroenterology 2000; 47: 1747-9.
4. WHITE TJ, EDNEY JA, THOMPSON JS, KARRER FW, MOOR BJ. Is there a prognostic difference between functional and nonfunctional islet cell tumors? Am J Surg 1994; 168: 627-30.
5. NORTON JA. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol 1999; 10 Suppl 4: 182-4.
6. PLOCKINGER U, WIEDENMANN B. Neuroendocrine tumors of the gastro enteropancreatic system: The role of early diagnosis, genetic testing and preventive surgery. Dig Dis 2002; 20: 49-60.
7. BRENTJENS R, SALTZ L. Islet cell tumors of the pancreas: The medical oncologist's perspective. Surg Clin North Am 2001; 81: 527-42.
8. MATTHEWS BD, SMITH TI, KERCHER KW, HOLDER WD JR, HENIFORD BT. Surgical experience with functioning pancreatic neuroendocrine tumors. Am Surg 2002; 68: 660-6.
9. MILLER J, DOHERTY GM. Tumores neuroendocrinos del páncreas. En: Burgos L (ed). Cirugía pancreática. Santiago: Arancibia Hnos y Cía Ltda 2002; 176-90.
10. MULLAN MH, GAUGER PG, THOMPSON NW. Endocrine tumours of the pancreas: Review and recent advances. ANZ J Surg 2001; 71: 475-82.
11. DOHERTY GM. Pancreatic endocrine tumors. Problems in General Surgery 2003; 20: 112-24.
12. PITRE J, SOUBRANE O, PALAZZO L, CHAPUIS Y. Endoscopic ultrasonography for the preoperative localization of insulinomas. Pancreas 1996; 13: 55-60.
13. HASHIMOTO LA, WALSH RM. Preoperative localization of insulinomas is not necessary. J Am Coll Surg 1999; 189: 368-73.
14. MABRUT JY, LIFANTE JC, CHERKI S, SIN S, BERGER N, PEIX JL. Is preoperative localization of insulinomas necessary? Ann Chir 2001; 126: 850-6.
15. LO CY, LAM KY, KUNG AW, LAM KS, TUNG PH, FAN ST. Pancreatic insulinomas. A 15 years experience. Arch Surg 1997; 132: 926-30.
16. HIRSHBERG B, LIBUTTI SK, ALEXANDER HR, BARTLETT DL, COCHRAN C, LIVI A ET AL. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg 2002; 194: 761-4.
17. BERENDS FJ, CUESTA MA, KAZEMIER G, VAN EIJCK CH, DE HERDER WW, VAN MUISWINKEL JM ET AL. Laparoscopic detection and resection of insulinomas. Surgery 2000; 128: 386-91.
18. LO CY, LO CM, FAN ST. Role of laparoscopic ultrasonography in intraoperative localization of pancreatic insulinoma. Surg Endosc 2000; 14: 1131-5.
19. SATO T, KONISHI K, KIMURA H, MAEDA K, YABUSHITA K, TSUJI M ET AL. Strategy for pancreatic endocrine tumors. Hepatogastroenterol 2000; 47: 537-9.
20. BURMEISTER R, BENAVIDES C, GARCÍA C, GONZÁLEZ C, MUNIZAGA F, DEVOTO E. Insulinoma. Rev Chil Cir 1997; 49: 206-8.
21. DE LA FUENTE H, SCHLACK C, CAIMI L, GONZÁLEZ R, MEGE RM. Insulinoma. Rev Chil Cir 1997; 49: 424-7.
22. JARUFE N, GUZMÁN S, LLANOS O, IBÁÑEZ A, VILLALÓN J. Insulinoma pancreático. Rev Chil Cir 2000; 52: 371-6.
23. TIOMNY E, BRILL S, BAKATZ M, MESSER G, GREIF F, MOSHKOWITZ M ET AL. Primary liver gastrinoma. J Clin Gastroenterol 1997; 24: 188-91.
24. WADA M, KOMOTO I, DOI R, IMAMURA M. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J Surg 2002; 26: 1291-6.
25. REUTER E, SEMLER P, BAER U, SIGISMUND R. Detection of a small gastrinoma by combined radiologie and scintigraphic techniques. Clin Nucl Med 1997; 22: 714-6.
26. ANDERSON MA, CARPENTER S, THOMPSON NW, NOSTRANT TT, ELTA GH, SCHELMAN JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000; 95: 2271-7.
27. ROY PK, VENZON DJ, SHOJAMANESH H, ABOU-SAIF A, PEGHINI P, DOPPMAN JL ET AL. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) 2000; 79: 379-411.
28. DESIR B, POITRAS P. Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome. Can J Gastroenterol 2001; 15: 795-8.
29. LEW EA, PISEGNA JR, STARR JA, SOFFER EF, FORSMARK C, MODLIN IM ET AL. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology 2000; 118: 696-704.
30. NORTON JA, FRAKER DL, ALEXANDER HR, VENZON DJ, DOPPMAN JL, SERRANO J ET AL. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999; 341: 635-44.
31. LI ML, NORTON JA. GASTRINOMA. Curr Treat Options Oncol 2001; 2: 337-46.
32. PARK BJ, ALEXANDER HR, LIBUTTI SK, HUANG J, ROYALTY D, SKARULIS MC ET AL. Operative management of islet cell tumors arising in the head of the pancreas. Surgery 1998; 124: 1056-62.
33. EL RASSI ZS, FERDINAND L, MOHSINE RM, BERGER F, LOMBARD-BOHAS C, BOILLOT O ET AL. Primary and secondary liver endocrine tumors: Clinical presentation, surgical approach and outcome. Hepatogastroenterology 2002; 49: 1340-6.
34. HELLMAN P, LADJEVARDI S, SKOGSEID B, AKERSTROM G, ELVIN A. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002; 26: 1052-6.
35. SHOJAMANESH H, GIBRIL, F, LOUIE A, OJEABURI JV, BASHIR S, ABOU-SAIF A ET AL. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. Cancer 2002; 94: 331-13.
36. HOUSE M, YEO CJ, SCHULICK RD. Periampullary pancreatic somatostatinoma. Annals of Surgical Oncology 2002; 9: 869-74.
37. FERNÁNDEZ-CRUZ L, SAENZ, A, ASTUDILLO E, MARTÍNIZ I, HOYOS S, PANTOJA JP ET AL. Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 2002; 26: 1057-65.
38. CHASTAIN MA. The glucagonoma syndrome: A review of its features and discussion of new perspectives. American Journal of the Medical Sciences 2001; 321: 306-20.
39. MAKOWKA L, TZAKIS AG, MAZZAFERRO V, TEPERMAN L, DEMETRIS AJ, IWATSUKI S ET AL. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989; 168: 107-11.
40. LAIRMORE TC, CHEN W, DEBENEDETTI MK, GILLANDERS WE, NORTON JA, DOHERTY GM. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Annals of Surgery 2000; 231: 909-18.
41. MATTHEWS BD, HENIFORD BT, REARDON PR, BRUNICARDI FC, GREENE FL. Surgical experience with non-functioning neuroendocrine tumors of the pancreas. Am Surg 2000; 66: 1116-23.
42. MAHER ER, KAELIN WG. von Hippei-Lindau disease. Medicine 1997; 76: 381-39.
43. SIMS KB. Von Hippel-Lindau disease: gene to bedside. Current Opinion in Neurology 2001; 14: 695-703.
44. DOHERTY GM, THOMPSON NW. Multiple endocrine neoplasia type I: duodenopancreatic tumours. J Intern Med 2003; 253: 590-98.